Pathogenic mutations inactivate parkin by distinct mechanisms

J Neurochem. 2005 Jan;92(1):114-22. doi: 10.1111/j.1471-4159.2004.02854.x.

Abstract

Loss of parkin function is the major cause of autosomal recessive Parkinson's disease (ARPD). A wide variety of parkin mutations have been identified in patients; however, the pathophysiological mechanisms leading to the inactivation of mutant parkin are poorly understood. In this study we characterized pathogenic C- and N-terminal parkin mutants and found distinct pathways of parkin inactivation. Deletion of the C terminus abrogated the association of parkin with cellular membranes and induced rapid misfolding and aggregation. Four N-terminal missense mutations, located within the ubiquitin-like domain (UBL), decrease the stability of parkin; as a consequence, these mutants are rapidly degraded by the proteasome. Furthermore, we present evidence that a smaller parkin species of 42 kDa, which is present in extracts prepared from human brain and cultured cells, originates from an internal start site and lacks the N-terminal UBL domain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Cell Line, Tumor
  • Gene Silencing*
  • Humans
  • Molecular Sequence Data
  • Mutation, Missense*
  • Parkinson Disease / enzymology
  • Parkinson Disease / genetics*
  • Parkinson Disease / metabolism*
  • Peptide Fragments / genetics
  • Peptide Fragments / metabolism
  • Proteasome Endopeptidase Complex / metabolism
  • Protein Folding
  • Protein Structure, Tertiary / genetics
  • Sequence Deletion
  • Transcription Initiation Site
  • Ubiquitin-Protein Ligases / antagonists & inhibitors
  • Ubiquitin-Protein Ligases / genetics*
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Peptide Fragments
  • Ubiquitin-Protein Ligases
  • parkin protein
  • Proteasome Endopeptidase Complex